Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Healthcare | Drug Manufacturers - Specialty & Generic | USA
statements
Index- P/E129.63 EPS (ttm)0.13 Insider Own5.10% Shs Outstand47.50M Perf Week-2.25%
Market Cap842.10M Forward P/E15.99 EPS next Y1.09 Insider Trans-7.78% Shs Float36.41M Perf Month-4.46%
Income6.70M PEG5.19 EPS next Q0.14 Inst Own56.50% Short Float7.01% Perf Quarter-4.14%
Sales337.30M P/S2.50 EPS this Y892.90% Inst Trans-0.15% Short Ratio11.92 Perf Half Y-14.83%
Book/sh8.53 P/B2.04 EPS next Y79.50% ROA1.10% Target Price21.80 Perf Year9.59%
Cash/sh2.04 P/C8.52 EPS next 5Y25.00% ROE1.70% 52W Range12.32 - 22.69 Perf YTD-13.63%
Dividend- P/FCF64.28 EPS past 5Y42.40% ROI-3.20% 52W High-22.17% Beta0.78
Dividend %- Quick Ratio1.70 Sales past 5Y8.90% Gross Margin41.50% 52W Low43.29% ATR0.53
Employees2027 Current Ratio2.90 Sales Q/Q4.10% Oper. Margin2.30% RSI (14)40.60 Volatility3.39% 2.78%
OptionableYes Debt/Eq0.11 EPS Q/Q200.50% Profit Margin2.00% Rel Volume0.68 Prev Close17.37
ShortableYes LT Debt/Eq0.08 Earnings- Payout0.00% Avg Volume214.13K Price17.66
Recom2.60 SMA20-4.05% SMA50-6.40% SMA200-9.91% Volume83,899 Change1.67%
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $21
Oct-05-20Upgrade Northland Capital Market Perform → Outperform $24
May-01-20Initiated Northland Capital Outperform $23
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Mar-13-19Downgrade Needham Buy → Hold
Aug-10-18Reiterated Needham Buy $24 → $22
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Feb-26-21 06:01AM  
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
GlobeNewswire
Feb-07-21 11:23PM  
What Percentage Of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Do Insiders Own?
Simply Wall St.
Dec-29-20 09:10AM  
Amphastar Surges on FDA Approval of Generic Hypoglycemia Injection
TheStreet.com
08:38AM  
Boeing, Apple, Cisco, Novavax - Tuesday's Premarket Movers
TheStreet.com
08:09AM  
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Benzinga
06:00AM  
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
GlobeNewswire
Dec-24-20 11:46PM  
Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Simply Wall St.
Dec-11-20 08:55AM  
Do Options Traders Know Something About Amphastar (AMPH) Stock We Don't?
Zacks
Dec-07-20 10:56AM  
Top Pharmaceutical Stocks for Q1 2021
Investopedia
Dec-03-20 09:25PM  
Where Do Hedge Funds Stand On Amphastar Pharmaceuticals Inc (AMPH)?
Insider Monkey
Nov-06-20 05:00PM  
Amphastar Pharmaceuticals Inc (AMPH) Q3 2020 Earnings Call Transcript
Motley Fool -6.93%
10:45AM  
Amphastar Pharmaceuticals, Inc. to Host Earnings Call
ACCESSWIRE
09:05AM  
Amphastar Pharmaceuticals (AMPH) Q3 Earnings Beat Estimates
Zacks
07:52AM  
Recap: Amphastar Pharmaceuticals Q3 Earnings
Benzinga
06:50AM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
GlobeNewswire
Nov-05-20 10:06AM  
Earnings Outlook For Amphastar Pharmaceuticals
Benzinga
Oct-30-20 12:30PM  
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
Zacks
Oct-29-20 04:05PM  
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020
GlobeNewswire
Oct-23-20 12:45PM  
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)
Zacks
Oct-14-20 07:26AM  
Amphastar's Shares March Higher, Can It Continue?
Zacks
06:10AM  
These 4 Measures Indicate That Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Using Debt Safely
Simply Wall St.
Oct-07-20 12:45PM  
3 Reasons Why Amphastar (AMPH) Is a Great Growth Stock
Zacks
Oct-06-20 06:00AM  
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
GlobeNewswire
Oct-05-20 10:44AM  
Price Over Earnings Overview: Amphastar Pharmaceuticals
Benzinga +6.00%
Sep-08-20 06:59AM  
Introducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 38% In The Last Five Years
Simply Wall St.
Sep-03-20 04:05PM  
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
GlobeNewswire
Aug-06-20 04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
GlobeNewswire
Aug-05-20 12:18PM  
Amphastar Pharmaceuticals's Earnings: A Preview
Benzinga
Aug-03-20 08:05AM  
Here's What Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Shareholder Ownership Structure Looks Like
Simply Wall St.
Jul-30-20 04:05PM  
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
GlobeNewswire
Jul-29-20 12:33PM  
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
Zacks
Jul-03-20 11:59AM  
Are Robust Financials Driving The Recent Rally In Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock?
Simply Wall St.
Jun-19-20 06:05AM  
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
GlobeNewswire
Jun-12-20 04:17PM  
Amphastar Pharmaceuticals Inc (AMPH): Hedge Funds In Wait-and-See Mode
Insider Monkey
06:30AM  
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
GlobeNewswire
Jun-09-20 09:52AM  
Dow Jones Today Set To Snap Win Streak, Stocks Lower As Airline Pullback: Dexcom Rallies On Price Hike
Investor's Business Daily
06:00AM  
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
GlobeNewswire
Jun-02-20 04:05PM  
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
GlobeNewswire
May-11-20 01:24AM  
Edited Transcript of AMPH earnings conference call or presentation 7-May-20 9:00pm GMT
Thomson Reuters StreetEvents
May-09-20 08:21AM  
Is Now The Time To Put Amphastar Pharmaceuticals (NASDAQ:AMPH) On Your Watchlist?
Simply Wall St.
May-08-20 04:31PM  
Amphastar Pharmaceuticals Inc (AMPH) Q1 2020 Earnings Call Transcript
Motley Fool +6.76%
May-07-20 04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
GlobeNewswire
May-06-20 12:10PM  
Why the Earnings Surprise Streak Could Continue for Amphastar (AMPH)
Zacks
May-04-20 06:01AM  
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
GlobeNewswire
Apr-27-20 06:00AM  
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
GlobeNewswire +7.47%
Apr-13-20 05:16PM  
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
GlobeNewswire
Apr-09-20 06:01AM  
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
GlobeNewswire
Mar-31-20 10:56AM  
Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
Thomson Reuters StreetEvents
Mar-29-20 08:36AM  
Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified?
Simply Wall St.
Mar-25-20 09:33AM  
Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
Zacks
Mar-24-20 09:47AM  
What Bargain Hunting? Tap 5 Stocks With Rising P/E
Zacks
Mar-20-20 10:44AM  
Generic Drugs Industry's Prospects Uncertain Amid Coronavirus
Zacks -5.17%
Mar-12-20 06:05PM  
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates
Zacks -9.35%
04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019
GlobeNewswire
03:00PM  
Amphastar Pharmaceuticals, Inc. to Host Earnings Call
ACCESSWIRE
Mar-05-20 04:05PM  
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020
GlobeNewswire
Mar-03-20 12:30PM  
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
Zacks
Feb-27-20 06:00AM  
Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL
GlobeNewswire
Feb-13-20 05:48AM  
Amphastar Pharmaceuticals (NASDAQ:AMPH) Could Easily Take On More Debt
Simply Wall St.
Jan-29-20 08:30AM  
The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut
Benzinga
Jan-28-20 04:05PM  
Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
GlobeNewswire
Jan-08-20 05:15AM  
Can You Imagine How Amphastar Pharmaceuticals's (NASDAQ:AMPH) Shareholders Feel About The 54% Share Price Increase?
Simply Wall St.
Dec-17-19 07:19PM  
Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)
Insider Monkey
Dec-10-19 10:25PM  
Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT
Thomson Reuters StreetEvents
Dec-02-19 05:16AM  
Based On Its ROE, Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) A High Quality Stock?
Simply Wall St.
Nov-27-19 06:00AM  
Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference
GlobeNewswire
Nov-15-19 06:00AM  
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GlobeNewswire
Nov-07-19 04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019
GlobeNewswire
Nov-01-19 06:00AM  
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019
GlobeNewswire
Oct-28-19 02:14PM  
Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?
Insider Monkey
Oct-21-19 06:17AM  
How Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Can Impact Your Portfolio Volatility
Simply Wall St.
Sep-21-19 07:58AM  
How Much Did Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pocket Last Year?
Simply Wall St.
Sep-12-19 09:15PM  
Amphastar Pharmaceuticals Inc (AMPH) CEO & Chief Scientific Officer Jack Y. Zhang Sold $6. ...
GuruFocus.com
Sep-01-19 09:38PM  
Edited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMT
Thomson Reuters StreetEvents
Aug-29-19 06:01AM  
Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference
GlobeNewswire
Aug-22-19 08:44AM  
Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet?
Simply Wall St.
Aug-07-19 11:24PM  
Amphastar Pharmaceuticals Inc (AMPH) Q2 2019 Earnings Call Transcript
Motley Fool
08:55PM  
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
Zacks
04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019
GlobeNewswire
Aug-05-19 06:00AM  
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019
GlobeNewswire
Jul-23-19 01:19PM  
Should You Be Holding Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)?
Simply Wall St.
Jun-29-19 06:18PM  
Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ?
Insider Monkey
Jun-24-19 06:00AM  
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
GlobeNewswire
Jun-19-19 06:00AM  
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
GlobeNewswire
Jun-14-19 02:07PM  
Introducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 33% In The Last Three Years
Simply Wall St.
06:00AM  
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
GlobeNewswire
May-31-19 06:00AM  
Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
GlobeNewswire
May-28-19 02:47PM  
7 Stocks to Buy for June
InvestorPlace
May-21-19 01:33AM  
Edited Transcript of AMPH earnings conference call or presentation 9-May-19 9:00pm GMT
Thomson Reuters StreetEvents
May-10-19 06:00AM  
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
GlobeNewswire
12:24AM  
Amphastar Pharmaceuticals Inc (AMPH) Q1 2019 Earnings Call Transcript
Motley Fool
May-09-19 07:05PM  
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass Estimates
Zacks
05:58PM  
Amphastar: 1Q Earnings Snapshot
Associated Press
04:05PM  
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
GlobeNewswire
May-07-19 10:56AM  
Heres What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)
Insider Monkey
May-06-19 06:00AM  
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019
GlobeNewswire
May-01-19 10:33AM  
Amphastar Pharmaceuticals (AMPH) to Report Q1 Results: Wall Street Expects Earnings Growth
Zacks
Apr-26-19 09:30AM  
MNK or AMPH: Which Is the Better Value Stock Right Now?
Zacks
Apr-25-19 03:13PM  
Do Insiders Own Shares In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)?
Simply Wall St.
Apr-15-19 09:30AM  
Small Cap Pot Stocks Can Bring Investors High Profits-THC Therapeutics, Inc.
ACCESSWIRE
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; naloxone for opioid overdose; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; and Cortrosyn, a lyophilized powder use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; lidocaine jelly, a local anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection for newborn babies; atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; morphine injection; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as recombinant human insulin API (active pharmaceutical ingredients) and porcine insulin API. Further, the company has a pipeline of 20 product candidates in various stages of development for various indications. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 18Sale18.584077,5626,827,679Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 17Sale18.6713,801257,7236,828,086Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 16Sale18.5116,259301,0316,841,887Feb 18 06:58 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 12Sale18.9413,277251,5226,858,146Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 11Sale19.0619,823377,8846,871,423Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 10Sale18.7615,747295,3446,891,246Feb 12 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 09Sale18.9311,927225,7766,906,993Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 08Sale18.8913,452254,0496,918,920Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 05Sale18.9415,507293,7216,932,372Feb 09 05:30 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 04Sale18.8925,570483,0206,947,879Feb 05 08:35 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 03Sale18.3616,299299,3236,973,449Feb 05 08:35 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 02Sale18.6613,817257,8216,989,748Feb 03 04:15 PM
Zhang Jack Y.CEO & Chief Scientific OfficerFeb 01Sale18.2924,114441,1207,003,565Feb 03 04:15 PM
Petersen Floyd F.DirectorFeb 01Sale18.2663911,66973,354Feb 02 04:16 PM
PETERS WILLIAM JCFO, SVP & TreasurerJan 19Sale18.676,495121,23789,548Jan 20 05:58 PM
Petersen Floyd F.DirectorDec 01Sale17.875008,93673,993Dec 02 04:20 PM
Petersen Floyd F.DirectorNov 02Sale19.845009,92074,493Nov 03 04:05 PM
Petersen Floyd F.DirectorOct 01Sale18.895009,44674,993Oct 02 04:15 PM
Petersen Floyd F.DirectorSep 01Sale19.905009,94875,493Sep 02 05:27 PM
Maris DavidDirectorAug 14Buy20.261,00020,26013,151Aug 18 04:15 PM
PETERS WILLIAM JCFO, SVP & TreasurerAug 14Sale20.365,512112,22395,652Aug 18 04:12 PM
PRINS RICHARD KDirectorAug 11Sale20.336,000121,97639,160Aug 12 06:34 PM
Petersen Floyd F.DirectorAug 03Sale20.6250010,30875,993Aug 04 08:22 PM
Liawatidewi YakobEVP Corp Admin CenterJul 21Option Exercise11.335,97867,73151,974Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 21Sale21.225,978126,83745,996Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 20Option Exercise11.334,18647,42750,182Jul 22 06:28 PM
Liawatidewi YakobEVP Corp Admin CenterJul 20Sale21.034,18688,04745,996Jul 22 06:28 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Option Exercise11.3310,000113,300114,820Jul 08 04:05 PM
PETERS WILLIAM JCFO, SVP & TreasurerJul 06Sale22.0013,656300,405101,164Jul 08 04:05 PM
Petersen Floyd F.DirectorJul 01Sale22.2750011,13676,493Jul 02 07:36 PM
Liawatidewi YakobEVP Corp Admin CenterJun 09Option Exercise10.9316,000174,88069,529Jun 10 07:39 PM
Liawatidewi YakobEVP Corp Admin CenterJun 09Sale20.4123,405477,60246,124Jun 10 07:39 PM
Zhou RongEVP, Production CenterJun 04Option Exercise11.418,918101,75489,042Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 04Sale19.199,806188,17779,236Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 03Option Exercise11.4111,082126,44693,287Jun 05 04:15 PM
Zhou RongEVP, Production CenterJun 03Sale18.8213,163247,67880,124Jun 05 04:15 PM
Petersen Floyd F.DirectorJun 01Sale18.975009,48371,142Jun 02 05:46 PM
Koo RichardDirectorMay 27Option Exercise15.1147,782721,986295,201May 28 04:05 PM
Koo RichardDirectorMay 27Sale18.1847,782868,892247,419May 28 04:05 PM
Lee HowardDirectorMay 26Option Exercise15.1110,000151,100138,081May 27 05:02 PM
Lee HowardDirectorMay 26Sale18.6010,000185,989128,081May 27 05:02 PM
Lee HowardDirectorMay 22Option Exercise15.1110,000151,100138,081May 27 05:02 PM
Lee HowardDirectorMay 22Sale18.3610,000183,639128,081May 27 05:02 PM
Lee HowardDirectorMay 21Option Exercise15.1110,000151,100138,081May 22 04:05 PM
Lee HowardDirectorMay 21Sale18.4710,000184,687128,081May 22 04:05 PM
Lee HowardDirectorMay 20Option Exercise15.1117,782268,686145,863May 22 04:05 PM
Lee HowardDirectorMay 20Sale18.4317,782327,779128,081May 22 04:05 PM
Petersen Floyd F.DirectorMay 15Option Exercise15.1142,682644,925114,324May 18 04:31 PM
ZASLOFF MICHAEL ADirectorMay 15Option Exercise15.1122,950346,77558,286May 18 04:36 PM
ZASLOFF MICHAEL ADirectorMay 15Sale18.0322,950413,68135,336May 18 04:36 PM
Petersen Floyd F.DirectorMay 15Sale18.2542,682778,96871,642May 18 04:31 PM
Petersen Floyd F.DirectorMay 14Option Exercise15.115,00075,55076,642May 18 04:31 PM
ZASLOFF MICHAEL ADirectorMay 14Option Exercise15.1114,832224,11250,168May 18 04:36 PM
ZASLOFF MICHAEL ADirectorMay 14Sale18.0014,832266,97635,336May 18 04:36 PM
Petersen Floyd F.DirectorMay 14Sale17.785,00088,87671,642May 18 04:31 PM
Petersen Floyd F.DirectorMay 12Option Exercise15.111001,51171,742May 14 04:15 PM
PRINS RICHARD KDirectorMay 12Option Exercise15.1130,282457,56169,591May 14 04:17 PM
ZASLOFF MICHAEL ADirectorMay 12Option Exercise15.1110,000151,10045,336May 14 04:18 PM
ZASLOFF MICHAEL ADirectorMay 12Sale19.0010,000190,00035,336May 14 04:18 PM
PRINS RICHARD KDirectorMay 12Sale19.0030,282575,41939,309May 14 04:17 PM
Petersen Floyd F.DirectorMay 12Sale19.201001,92071,642May 14 04:15 PM
Petersen Floyd F.DirectorMay 01Sale16.665008,32971,642May 05 05:05 PM
Petersen Floyd F.DirectorApr 01Sale14.365007,18172,142Apr 02 05:46 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 13Sale13.944,70165,53974,274Mar 17 08:07 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.